PlainRecalls
FDA Devices Moderate Class II Terminated

BIOTRONIK ITREVIA 7, VR-T DF-1, REF 393040, UDI: 04035479129552 - Product Usage: intended to provide ventricular tachycardia pacing and ventricular defibrillation for automatic treatment of life-threatening ventricular arrhythmias.

Reported: April 28, 2021 Initiated: March 8, 2021 #Z-1451-2021

Product Description

BIOTRONIK ITREVIA 7, VR-T DF-1, REF 393040, UDI: 04035479129552 - Product Usage: intended to provide ventricular tachycardia pacing and ventricular defibrillation for automatic treatment of life-threatening ventricular arrhythmias.

Reason for Recall

There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)

Details

Recalling Firm
BIOTRONIK Inc
Units Affected
499 units
Distribution
US: Nationwide OUS: Worldwide
Location
Lake Oswego, OR

Frequently Asked Questions

What product was recalled?
BIOTRONIK ITREVIA 7, VR-T DF-1, REF 393040, UDI: 04035479129552 - Product Usage: intended to provide ventricular tachycardia pacing and ventricular defibrillation for automatic treatment of life-threatening ventricular arrhythmias.. Recalled by BIOTRONIK Inc. Units affected: 499 units.
Why was this product recalled?
There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
Which agency issued this recall?
This recall was issued by the FDA Devices on April 28, 2021. Severity: Moderate. Recall number: Z-1451-2021.